OHSU

Atul A. Deodhar, MD, MRCP, FACP, FACR

Atul Deodhar, MD, MRCP, FACP, FACR

Atul A. Deodhar, MD, MRCP, FACP, FACR
Professor of Medicine, OHSU
Medical Director, Rheumatology Clinics
Medical Director, Immunology Infusion Center

Education and Training

Medical School: B.J. Medical College, Pune, India
IM Residency: Sassoon General Hospital and King Edward Memorial hospital, Pune, India, and also Royal Cornwall Hospital, Truro, England.
Rheumatology Fellowship: Oregon Health & Science University, Portland, OR

Biography

Through his role on the Executive Committee of the SpondyloArthritis Research and Treatment Network (SPARTAN), Dr. Deodhar has been dedicated to spondyloarthritis research, including epidemiology, diagnosis, and treatment strategies.  He has been engaged in clinical trials assessing the efficacy of novel therapies in ankylosing spondylitis and psoriatic arthritis. Together with the Department of Dermatology, he has created the Center for Psoriasis and Psoriatic Arthritis Excellence (CEPPA) at OHSU, a multidisciplinary clinic which has provided care for patients with psoriasis and psoriatic arthritis and allowed the collection and analysis of a CEPPA registry.  Dr Deodhar has also published in the field of osteoporosis specifically as it relates to inflammatory arthritis and has been interested in the use of hand bone densitometry to monitor progression of inflammatory arthritis.  As a fellow, Dr. Deodhar worked with Dr. Robert Bennett on understanding various aspects of fibromyalgia including its diagnosis and treatment.  Dr. Deodhar has completed the Train-the-trainer USSONAR course in musculoskeletal ultrasound and is conducting an ultrasound guided injection clinic that fellows attend. 

Recent Publications

  1. Braun J, Deodhar A, Inman R. et al. Golimumab, administered subcutaneously every 4 weeks, in ankylosing spondylitis: 104-week efficacy and safety results of a randomized, placebo-controlled study. Ann Rheum Dis. 2012 May;71(5):661-7.  
  2. Deodhar A. Update in Rheumatology: Evidence published in 2012. Ann Int Med. 2013 (In Press)  
  3. van der Heijde D, Braun J, Deodhar A, et al. Comparison of three enthesitis indices in a multicentre, randomized, placebo-controlled trial of golimumab in ankylosing spondylitis (GO-RAISE). Rheumatology (Oxford). 2013 Feb;52(2):321-5.

 

Back to ARD Faculty Listing